Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17362239rdf:typepubmed:Citationlld:pubmed
pubmed-article:17362239lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:17362239lifeskim:mentionsumls-concept:C0033308lld:lifeskim
pubmed-article:17362239lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:17362239lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:17362239lifeskim:mentionsumls-concept:C1260879lld:lifeskim
pubmed-article:17362239lifeskim:mentionsumls-concept:C0442726lld:lifeskim
pubmed-article:17362239lifeskim:mentionsumls-concept:C1510438lld:lifeskim
pubmed-article:17362239lifeskim:mentionsumls-concept:C0332324lld:lifeskim
pubmed-article:17362239pubmed:issue4lld:pubmed
pubmed-article:17362239pubmed:dateCreated2007-5-31lld:pubmed
pubmed-article:17362239pubmed:abstractTextAutoimmune progesterone dermatitis (APD) is a rare cutaneous disorder, characterized by recurrent polymorphous cutaneous and mucosal manifestations. It is considered to be caused by a hypersensitive reaction to endogenous progesterone. However, in vitro T-cell activity to this hormone has been described in few patients. Here we report the case of a 30-year-old woman with recurrent pruritic erythematous, and erythema multiforme-like eruptions localized to the genital area. Positive cutaneous reaction to intradermal progesterone injection suggested the diagnosis of APD. The analysis of cellular immune response to progesterone, investigated by the ELISpot assay, showed a significantly higher level of Interferon-gamma (IFN-gamma) producing cells in this patient compared with a control group comprising five asymptomatic women in the luteal phase of the menstrual cycle. Our results suggest that the ELISpot technique, together with clinical evaluations and assessment of allergies, could be useful in the diagnosis of APD.lld:pubmed
pubmed-article:17362239pubmed:languageenglld:pubmed
pubmed-article:17362239pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17362239pubmed:citationSubsetIMlld:pubmed
pubmed-article:17362239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17362239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17362239pubmed:statusMEDLINElld:pubmed
pubmed-article:17362239pubmed:monthJullld:pubmed
pubmed-article:17362239pubmed:issn0307-6938lld:pubmed
pubmed-article:17362239pubmed:authorpubmed-author:PicardoMMlld:pubmed
pubmed-article:17362239pubmed:authorpubmed-author:PietravalleMMlld:pubmed
pubmed-article:17362239pubmed:authorpubmed-author:CristaudoAAlld:pubmed
pubmed-article:17362239pubmed:authorpubmed-author:PalamaraFFlld:pubmed
pubmed-article:17362239pubmed:authorpubmed-author:BordignonVVlld:pubmed
pubmed-article:17362239pubmed:authorpubmed-author:De RoccoMMlld:pubmed
pubmed-article:17362239pubmed:issnTypePrintlld:pubmed
pubmed-article:17362239pubmed:volume32lld:pubmed
pubmed-article:17362239pubmed:ownerNLMlld:pubmed
pubmed-article:17362239pubmed:authorsCompleteYlld:pubmed
pubmed-article:17362239pubmed:pagination439-41lld:pubmed
pubmed-article:17362239pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:meshHeadingpubmed-meshheading:17362239...lld:pubmed
pubmed-article:17362239pubmed:year2007lld:pubmed
pubmed-article:17362239pubmed:articleTitleProgesterone sensitive Interferon-gamma producing cells detected by ELISpot assay in autoimmune progesterone dermatitis.lld:pubmed
pubmed-article:17362239pubmed:affiliationDepartment of Allergology, St. Callicano Institute, Rome, Italy.lld:pubmed
pubmed-article:17362239pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17362239pubmed:publicationTypeCase Reportslld:pubmed